Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study

l'ANI (Analgesia Nociception Index

The main objective of the research is to estimate the Analgesia Nociception Index (ANI) as a parameter giving the possibility of measuring the pain in painful metastatic cancer. The parameter ANI is compared with visual analogical scale (VAS) score.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Cancer Neoplasms Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital Foch

Suresnes, 92150, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

more than 18 years, -no legal protection, -
life expectancy is considered over 3-months
not receiving of béta-blocking,
Having a rhythm sinusal without extrasystole
benefiting from a coverage by a social security system

Exclusion criteria

Pace-Maker
Diabetes mellitus

Treatment and study plan

Non Invasive Monitoring Device (ANI)

Device

Pain measure by ANI monitor and with visual analogical scale

Primary outcomes

Comparison of the ANI parameter with the VAS

Time frame: 4 hours

Sponsors and collaborators

Lead sponsor

Hopital Foch

Other

Registry information

Acronym: ANIONCO

Important dates

Study start: 2012
Primary completion: 2016
Study completion: 2016
First posted: Sep 16, 2016
Registry last updated: Feb 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed